The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 23rd 2025
Orforglipron showed promising results in managing type 2 diabetes, offering a potential oral alternative to injectable treatments.
Study Examining Higher Chloroquine Doses in COVID-19 Halted Early Due to Safety Concerns
April 14th 2020A study based in Brazil has been halted early for safety reasons after patients with coronavirus disease 2019 taking a higher dose of chloroquine developed irregular heart rates that increased their risk of a potentially fatal heart arrhythmia.
Read More
Limited Global Supply, Ethical Concerns Could Curb Use of Antimalarials Against COVID-19
April 13th 2020Although chloroquine and hydroxychloroquine have been touted as potential treatments for COVID-19, physicians in Italy have warned that the global supply may not be able to keep up with demand.
Read More
Pharmacy Students Graduating Early to Cover Potential Pharmacy Staff Shortage in COVID-19 Pandemic
April 13th 2020Purdue University’s College of Pharmacy is granting early graduation to 144 students to help cover a potential shortage of pharmacists during the coronavirus disease 2019 pandemic.
Read More
Autoimmunity-Associated Heart Dilation Linked to Heart Failure Risk in Type 1 Diabetes
April 13th 2020Individuals with type 1 diabetes, specifically those with poor glycemic control, are at an greater risk for cardiovascular disease than the general population, according to a study by Joslin Research.
Read More
New Clinical Trial Developed to Fast-Track COVID-19 Therapies
April 10th 2020Derek Angus, MD, MPH and his collaborators had developed a platform called REMAP-Community Acquired Pneumonia (REMAP-CAP), which was designed to find optimal treatment for severe pneumonia both in non-pandemic and pandemic settings.
Read More
Federal Guidance Allowing Pharmacists to Provide COVID-19 Testing Applauded by Health Care Leaders
April 9th 2020US Department of Health and Human Services (HHS) Secretary Alex Azar released a statement on how the authorization for pharmacists will mean easier access for patients who need COVID-19 testing.
Read More
New Wearable, Patch-Like Insulin Delivery System for Patients with Type 2 Diabetes
April 8th 2020Adult patients with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin in a wearable, patch-like insulin delivery device called V-Go.
Read More
ASHP Survey Finds Severe Supply Disruption in Medical Masks
April 8th 2020The American Society of Health-System Pharmacists (ASHP) is surveying members of the Section of Pharmacy Practice leaders on a bi-weekly basis to obtain the real-time status of medical supplies during the coronavirus disease 2019 (COVID-19) pandemic.
Read More